[go: up one dir, main page]

CN106588897A - New preparation method of Pranlukast - Google Patents

New preparation method of Pranlukast Download PDF

Info

Publication number
CN106588897A
CN106588897A CN201710110643.5A CN201710110643A CN106588897A CN 106588897 A CN106588897 A CN 106588897A CN 201710110643 A CN201710110643 A CN 201710110643A CN 106588897 A CN106588897 A CN 106588897A
Authority
CN
China
Prior art keywords
acid
pranlukast
phenol
alkali
benzamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710110643.5A
Other languages
Chinese (zh)
Inventor
刘辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Micro Giant Industrial Co Ltd
Original Assignee
Shanghai Micro Giant Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Micro Giant Industrial Co Ltd filed Critical Shanghai Micro Giant Industrial Co Ltd
Priority to CN201710110643.5A priority Critical patent/CN106588897A/en
Publication of CN106588897A publication Critical patent/CN106588897A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides a new preparation method of drug Pranlukast for treating asthma. The new preparation method includes the specific steps that with 2-aminophenol-4-sulfonic acid as a starting material, a key intermediate 3-amino-2-hydroxyacetophenone is prepared by means of acylation, Fries rearrangement and deprotection, then reacts with 4-(phenylbutoxy)benzoic acid, and then is subjected to condensation with ethyl 1H-tetrazole-5-acetate, and finally preparation is achieved through ring closing under the acidic condition. Compared with the prior art, the raw material used for the new preparation method is low in price and easy to obtain, industrialization of a process can be achieved easily, and the obtained final product is high in purity; and no dangerous process exists, equipment is simple, and the route is novel.

Description

A kind of new preparation process of pranlukast
Technical field
The present invention relates to field of medicaments, specifically a kind of new preparation process of pranlukast.
Background technology
Pranlukast (pranlukast, 1), chemical entitled N- [4- oxo -2- (1H-TETRAZOLE -5- bases) -4H-1- benzo pyrroles Mutter -8- bases] -4- (4- phenylbutoxies) Benzoylamide, it is the LTRA of Japanese Ono companies research and development, nineteen ninety-five First in Japan's listing, clinic is mainly used as asthma and antiallergic agent.To preventing and treating Zhong Er Yan ﹑ dysmenorrheas and psoriasises etc. There is good efficacy；Simultaneously animal cerebral ischemia is significantly improved, and Central nervous system untoward reaction is light.
The synthesis of existing pranlukast has following several：
1st, patent：WO2005077942 reports the synthesis of pranlukast with the iodo- 2- hydroxy acetophenones of 3- as initiation material, with four nitrogen Azoles ethyl ester is condensed, and then dehydration condensation is condensed to yield pranlukast with to benzene butyl phenyl ether Methanamide.Initiation material in the technique Synthesis difficulty is larger, relatively costly.Concrete route is as follows：
2nd, patent：The synthesis of EP0173516 report pranlukasts is with 8- amino -4- oxo -2-（5-1H-4 oxazolyls）- 4H-1- benzene And pyrans and compound to the chloride compounds of benzene butoxybenzoic acid through acylation reaction, one-step synthesis pranlukast.The work Skill route is only completed through a step, but the Material synthesis step needed for the technique is more, and route is long, and yield is low, high cost.Specifically Route is as follows：
And 8- amino -4- oxo -2-（5-1H-4 oxazolyls）The synthetic route of -4H-1- .alpha.-5:6-benzopyrans is as follows, and which is with 3- nitro -2- Hydroxy acetophenone is raw material, and Jing condensations, dehydration condensation, ammonolysis are dehydrated into nitrile, and cyano compound is being synthesized with reaction of sodium azide Tetrazole ring, is preparing 8- amino -4- oxo -2- through hydro-reduction（5-1H-4 oxazolyls）- 4H-1- .alpha.-5:6-benzopyrans.Such as Document：Journal of Medicinal Chemistry. 1988,31(1).84-91.
In addition, the synthesis of 3- nitro -2- hydroxy acetophenones has two lines.Scheme one, such as patent WO 2009085256 is with 2- hydroxyls Benzoylformaldoxime is that raw material Jing nitrifications are obtained, but yield is relatively low；Scheme two, such as document Synthesis, 2004,11：1789- 1792 with adjacent nitro acetophenol as raw material, the radiation synthesis under microwave, although yield is higher, but is not suitable for big production.
Additionally, 8- amino -4- oxo -2-（5-1H-4 oxazolyls）The synthesis of -4H-1- .alpha.-5:6-benzopyrans can also by 3- amino - 2- hydroxy acetophenones are raw material, with tetrazoleacetic acid ester condensation in the presence of two silicon substrate amine of hexamethyl and n-BuLi, are reset, Cyclization is prepared.The process overall yields 41.3%, but the hazardous agents such as the n-BuLi of costliness are used, and reaction condition is severe Carve.3- amino -2- hydroxy acetophenone market prices are more expensive simultaneously.Concrete route is as follows：
3rd, patent WO9532199 is also with 8- amino -4- oxo -2-（5-1H-4 oxazolyls）- 4H-1- .alpha.-5:6-benzopyrans are former for starting Material.Simultaneously under the reagent such as palladium catalyst and DBU, CO (carbon monoxide converter) gas are passed through, with bromobenzene butyl phenyl ether through being condensed to yield Pranlukast.The technique has gone out Material synthesis difficulty greatly, on the other hand uses the palladium catalyst of costliness and a poisonous oxidation Carbon gas, therefore it is unfavorable for industrialized production.Concrete route is as follows：
4th, with p bromophenol as raw material, Jing is acylated patent WO9734885, and Fries resets, nitrification, condensation simultaneously cyclization, then palladium carbon Catalysis reduction-debromination, obtains 2- Ethyl formate -8- nitro -4- oxo -4H-1- .alpha.-5:6-benzopyrans.But the yield of this step debrominate Only 55%.Product after debrominate produces 8- amino -4- oxo -2- (5-1H- with reaction of sodium azide through ammonolysis, dehydration Tetrazole radical) -4H-1- .alpha.-5:6-benzopyrans.The process route is long, uses palladium carbon catalysis reduction, complex operation, cost in route twice Height, is unfavorable for large-scale production.Concrete route is as follows：
5th, the preparation method of the pranlukast of patent WO9412492 report is with N- (3- acetyl group -2- hydroxy phenyls) -4- (4- Butoxy phenyl) this Methanamide and tetrazoleacetic acid ester condensation, then cyclization is into the preparation method of pranlukast.The technique is not given Go out the synthetic route of initiation material, also do not provide the yield of each step reaction.Its synthetic route is as follows：
6th, the method for the synthesis pranlukast of patent WO9725040 report is with intermediate 8- amino -4- oxo -2- (5-1H- tetra- Oxazolyl) protection of -4H-1- .alpha.-5:6-benzopyrans and acetal the acyl chlorides compound Jing condensation reaction to benzene butoxybenzoic acid, then slough guarantor Shield base, synthetically prepared pranlukast.The initiation material that the technique is used needs multistep reaction synthesis to obtain, relatively costly.
7th, the synthetic method of the pranlukast of patent WO9734885 report is with N- (3- acetyl group -2- hydroxy benzeness second Base) -4- (4- butoxy phenyls) this Methanamide and tetrazoleacetic acid sodium is condensed, and after rearrangement, cyclization obtains pranlukast again.The work There is no the synthetic method for reporting two initiation materials in skill, according to the report of other pertinent literatures, the conjunction of the two initiation materials Obtain into multistep reaction is needed.Concrete route is as follows：
8. the method for the synthesis pranlukast of patent WO9600225 report is the tetrazoleacetic acid ester and N- to protect（3- acetyl Base -2- hydroxy phenyls）-4-（4- butoxy phenyls）This Methanamide is condensed, and takes off the synthesis of amino protecting group after cyclization dehydration again Method.The technique is larger in the tetrazole difficulty of synthetic nitrogen upper band substituent group, and final deprotection reaction uses tetrahydrochysene lithium aluminium etc. Expensive hazardous agents, complex operation, high cost are unfavorable for large-scale production.Concrete route is as follows：
9th, patent WO9531445 is with 8- [4- with regard to the synthesis of pranlukast（4- butoxy phenyls）This Methanamide] amine -4- oxygen Generation -4H-1- .alpha.-5:6-benzopyran -2- nitriles are raw material, under the catalysis of triethylamine, produce one similar to the knot narrowed with hydrazine hydrate effect Structure is passed through H2S gases, generate thioamides, then the amidine structural compounds with hydrazine effect production project, and the compound exists again React with sodium nitrite in aqueous acetic acid, cyclization production tetrazole is obtained pranlukast.The synthesis technique reactions steps are more, Also need to hydrazine reaction same at low temperature, expensive, complex operation.With hydrogen sulfide gas, also it is unfavorable for operating and keeping the safety in production. The synthetic method of initiation material is not reported simultaneously.Concrete synthetic route is as follows：
The content of the invention
It is an object of the invention to provide a kind of new preparation process of pranlukast, to solve to propose in above-mentioned background technology Problem.
Synthetic route of the present invention is as follows：
The present invention provides following technical scheme：
A kind of preparation method for treating asthmatic medicament pranlukast, comprises the following steps：
The first step：The preparation of 3- acetamido -4- acetyloxybenzenesulfonic acids（I）
With Ortho-Aminophenol -4- sulfonic acid and acetic anhydride as raw material, mol ratio is 1:2.1, in polar solvent, exist in alkali or acid Under 3- acetamido -4- acetyloxybenzenesulfonic acids are synthesized（I）.
Solvent therein selects acetic acid, methanol, ethanol, pyridine, DMF, dichloromethane, chloroform etc..It is preferred that methanol, ethanol. Alkali selects pyridine, DMAP, triethylamine, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, diisopropylethylamine etc., preferred pyrrole Pyridine, triethylamine.Acid selects concentrated sulphuric acid, p-methyl benzenesulfonic acid, PPA etc..It is preferred that concentrated sulphuric acid.
I
Second step：The preparation of 3- amino -2- hydroxy acetophenones（II）
One pot process 3- amino -2- hydroxy acetophenones.3- acetamido -4- acetoxy acetophenones in aprotic solvent, Jing Catalyzed by Anhydrous Aluminium Chloride carries out Fries rearrangements, acid hydrolysis one pot process 3- amino -2- hydroxy acetophenones.
Solvent therein selects Nitrobenzol.Acid selects dilute sulfuric acid, dilute hydrochloric acid.It is preferred that dilute hydrochloric acid.
II
3rd step：The preparation (III) of 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol
The quality reaction synthesis acyl chlorides such as 4- (benzene butoxy) benzoic acid and thionyl chloride, reaction temperature room temperature-backflow, response time 2-8h, then the complete thionyl chloride of recovered under reduced pressure unreacted, is then synthesized with 3- amino -2- hydroxy acetophenones at low temperature 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol (III).
Chloride can select thionyl chloride, oxalyl chloride, preferred thionyl chloride.Acylated solvent selects dichloromethane, chlorine Imitative, ethyl acetate, tetrahydrofuran etc..It is preferred that dichloromethane.Alkali inorganic base or organic base, such as sodium hydroxide, potassium hydroxide, carbon Sour sodium, potassium carbonate, triethylamine, diisopropylethylamine, pyridine, DMAP etc., preferred pyridine, triethylamine.Reaction temperature is controlled at 5 DEG C Below.Response time 2-3h.
III
4th step：The preparation of 2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol (IV)
It is molten that 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol is dissolved in aprotic, polar with tetrazole Ethyl formate In agent, mol ratio is 1:(1.05-1.1), condensation reaction is carried out under base catalysiss synthesize 2- [4- (4- benzene butoxy) benzoyls Amino] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol (IIII).Temperature control room temperature is to 90 DEG C.Response time 1-2h.
Solvent selects methanol, ethanol, DMF.Alkali select Feldalat NM, Sodium ethylate, potassium tert-butoxide, potassium hydroxide, sodium hydroxide, Sodamide. etc..It is preferred that potassium tert-butoxide.
IV
5th step：The preparation (V) of pranlukast
2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol is dissolved in dehydrated alcohol, Under acid catalysiss, back flow reaction synthesis pranlukast (V) is to slowly warm up to.Acid concentrated sulphuric acid, it is 1 that consumption is mol ratio:1.
V
Compared with prior art, the invention has the beneficial effects as follows：Raw materials used low price is easy to get, and technique easily realizes industry Change, gained final products purity is high.Without dangerous technique, equipment is simple, and route is novel.
Specific embodiment
Technical scheme in the embodiment of the present invention will be clearly and completely described below, it is clear that described embodiment is only Only it is a part of embodiment of the invention, rather than the embodiment of whole.Based on the embodiment in the present invention, ordinary skill The every other embodiment obtained under the premise of creative work is not made by personnel, belongs to the scope of protection of the invention.
Embodiment 1：The preparation (I) of 3- acetamido -4- acetyloxybenzenesulfonic acids
Take Ortho-Aminophenol -4- sulfonic acid (189g), acetic anhydride（224g）, methanol 400g, 10 milliliters of concentrated sulphuric acid, back flow reaction 4h. After reaction terminates, recovered under reduced pressure methanol is cooled to room temperature, adds saturated sodium bicarbonate solution to adjust to pH9- in reaction system 10,400 milliliters of ethyl acetate extractions, are washed to neutrality, and anhydrous sodium sulfate drying is filtered, and decompression and solvent recovery obtains light yellow solid Body 264g, yield 97%.
Embodiment 2：The synthesis of 3- amino -2- hydroxy acetophenones.
3- acetamido -4- acetyloxybenzenesulfonic acid 136g are taken, is dissolved in 300 milliliters of Nitrobenzol, add anhydrous tri-chlorination Aluminum 133g, is heated to reflux 5h, and after reaction terminates, recovered under reduced pressure major part solvent is cooled to room temperature, and under ice bath, reactant liquor is slow It is added in 30% dilute hydrochloric acid, 2h is stirred at room temperature, be to slowly warm up to backflow, react 4h, after reaction terminates, reactant liquor is cooled to Room temperature, adds 20% sodium hydroxide solution to adjust pH9-10 in reaction system.300 milliliters of chloroform extractions are added, in being washed to Property, anhydrous sodium sulfate drying, filtration, filtrate decompression recovery, residue petroleum ether：Ethyl acetate=1:3 recrystallization it is light yellow solid Body 65.7g, yield 87%.
Embodiment 3：The preparation (III) of 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol
4- (benzene butoxy) benzoic acid 270g is taken, adds 270g thionyl chlorides, 50 DEG C of insulation reaction 3h after reaction terminates, to reduce pressure Reclaim the complete thionyl chloride of unreacted.It is passed through nitrogen and blows off thionyl chloride.Being cooled to room temperature adds 270g dichloromethane standby.Claim Take 151g 3- amino -2- hydroxy acetophenones to be dissolved in 200g dichloromethane, add pyridine 160g, Deca 4- (benzene fourth under ice bath Epoxide) Benzenecarbonyl chloride. dichloromethane solution, during Deca temperature be less than 10 DEG C, completion of dropping, 10 DEG C of insulation reaction 2h, After reaction terminates, dilute hydrochloric acid is added in reaction system, pH is adjusted to 2-3, point liquid, dichloromethane layer is washed to neutrality, anhydrous Sodium sulfate is dried, and filters, and concentration obtains red brown solid, petroleum ether：Ethyl acetate=1:1 is recrystallized to give 334g, yield 84%.
Embodiment 4：2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol Prepare (IV)
2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol 202g is taken, is dissolved in 300 milliliters of DMF, delayed under ice bath It is slow add potassium tert-butoxide 224g, addition to finish after, react 1h under ice bath, backward system in Deca tetrazole Ethyl formate 80g DMF solution（DMF, 100 milliliters）, completion of dropping, system are to slowly warm up to 80 DEG C of reaction 1h.After reaction terminates, recovered under reduced pressure Most of solvent, afterwards residue be cooled to room temperature, be poured slowly in 500 milliliters of frozen water, adjusted to pH2-3 with dilute hydrochloric acid, in a large number Yellow solid is separated out, and is filtered, and filter cake is washed to neutrality, is vacuum dried to obtain crude product 232g, yield 91%.
Embodiment 5：The preparation (V) of pranlukast
4.2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol 232g is taken, is dissolved in In 400 milliliters of dehydrated alcohol, 90g concentrated sulphuric acids under ice bath, are slowly added dropwise, after completion of dropping, are to slowly warm up to backflow, after reaction 2h, Reaction terminates, and is cooled to room temperature, and a large amount of white solids are separated out, and are filtered, and filter cake ice washing with alcohol, 70% ethyl alcohol recrystallization are obtained White solid 207g, yield 93%.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, Er Qie In the case of spirit or essential attributes without departing substantially from the present invention, the present invention can be realized in other specific forms.Therefore, no matter From the point of view of which point, embodiment all should be regarded as exemplary, and be nonrestrictive, the scope of the present invention is by appended power Profit is required rather than described above is limited, it is intended that all in the implication and scope of the equivalency of claim by falling Change is included in the present invention.Any reference in claim should not be considered as and limit involved claim.
Moreover, it will be appreciated that although this specification is been described by according to embodiment, not each embodiment is only wrapped Containing an independent technical scheme, this narrating mode of description is only that those skilled in the art should for clarity Using description as an entirety, the technical scheme in each embodiment can also Jing it is appropriately combined, form those skilled in the art Understandable other embodiment.

Claims (6)

1. a kind of new preparation process of pranlukast, it is characterised in that including following synthesis steps：
（1）The preparation of 3- acetamido -4- acetyloxybenzenesulfonic acids（I）：
With Ortho-Aminophenol -4- sulfonic acid and acetic anhydride as raw material, mol ratio is 1:2.1, in polar solvent, exist in alkali or acid Under 3- acetamido -4- acetyloxybenzenesulfonic acids are synthesized（I）, reaction equation is：
（I）
Wherein, polar solvent is acetic acid, methanol, ethanol, pyridine, DMF, dichloromethane or chloroform, and alkali is pyridine, DMAP, three second Amine, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate or diisopropylethylamine, acid are concentrated sulphuric acid, p-methyl benzenesulfonic acid or PPA；
（2）The preparation of 3- amino -2- hydroxy acetophenones（II）：
In atent solvent, under Catalyzed by Anhydrous Aluminium Chloride, compound I occur Fries reset, Jing acid hydrolysis, obtain 3- amino- 2- hydroxy acetophenones, reaction equation is：
（II）
Wherein, solvent is Nitrobenzol, and acid is dilute sulfuric acid or dilute hydrochloric acid；
（3）The preparation (III) of 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol：
4- (benzene butoxy) benzoic acid and thionyl chloride are synthesized acyl chlorides, reaction temperature room temperature-backflow, response time 2-8h, Then the complete thionyl chloride of recovered under reduced pressure unreacted, is then synthesized 2- second with 3- amino -2- hydroxy acetophenones at low temperature Acyl group -6- [4- (4- benzene butoxy) benzamido] phenol (III), response time 2-3h, reaction equation is：
（III）
Wherein, acylated solvent is dichloromethane, chloroform, ethyl acetate or tetrahydrofuran, and alkali is inorganic base or organic base, is hydrogen Sodium oxide, potassium hydroxide, sodium carbonate, potassium carbonate, triethylamine, diisopropylethylamine, pyridine or DMAP；
（4）The preparation (IV) of 2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol：
It is molten that 2- acetyl group -6- [4- (4- benzene butoxy) benzamido] phenol is dissolved in aprotic, polar with tetrazole Ethyl formate In agent, mol ratio is 1：1.05-1.1, carries out condensation reaction synthesis 2- [4- (4- benzene butoxy) benzene carbon amides under base catalysiss Base] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol (IIII), to 90 DEG C, response time 1-2h reacts temperature control room temperature Formula is：
（IV）
Wherein, solvent be methanol, ethanol or DMF, alkali be Feldalat NM, Sodium ethylate, potassium tert-butoxide, potassium hydroxide, sodium hydroxide or Sodamide.；
（5）The preparation (V) of pranlukast：
2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3- tetrazole bases) phenol is dissolved in dehydrated alcohol, Under acid catalysiss, back flow reaction synthesis pranlukast (V) is to slowly warm up to, reaction equation is：
（V）
Wherein acid concentrated sulphuric acid, consumption is and 2- [4- (4- benzene butoxy) benzamido] -6- (1,3- dicarbapentaborane -3-, four nitrogen Oxazolyl) phenol mol ratio 1:1.
2. the new preparation process of pranlukast according to claim 1, it is characterised in that step（1）In polar solvent For methanol or ethanol, alkali is pyridine or triethylamine, and acid is concentrated sulphuric acid.
3. the new preparation process of pranlukast according to claim 1, it is characterised in that step（2）In acid be dilute salt Acid.
4. the new preparation process of pranlukast according to claim 1, it is characterised in that step（3）In acylation it is molten Agent is dichloromethane, and alkali is pyridine or triethylamine.
5. the new preparation process of pranlukast according to claim 1, it is characterised in that step（3）In low temperature for control System is below 5 DEG C.
6. the new preparation process of pranlukast according to claim 1, it is characterised in that step（4）Middle alkali is the tert-butyl alcohol Potassium.
CN201710110643.5A 2017-02-28 2017-02-28 New preparation method of Pranlukast Pending CN106588897A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710110643.5A CN106588897A (en) 2017-02-28 2017-02-28 New preparation method of Pranlukast

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710110643.5A CN106588897A (en) 2017-02-28 2017-02-28 New preparation method of Pranlukast

Publications (1)

Publication Number Publication Date
CN106588897A true CN106588897A (en) 2017-04-26

Family

ID=58588134

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710110643.5A Pending CN106588897A (en) 2017-02-28 2017-02-28 New preparation method of Pranlukast

Country Status (1)

Country Link
CN (1) CN106588897A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106995366A (en) * 2017-06-07 2017-08-01 上海微巨实业有限公司 A kind of novel preparation method of the hydroxy acetophenone of 3 amino 2
CN107098822A (en) * 2017-06-07 2017-08-29 上海微巨实业有限公司 A kind of preparation method for preparing the hydroxy acetophenone of 3 amino of Pranlukast key intermediate 2
CN108947984A (en) * 2018-09-17 2018-12-07 烟台万润药业有限公司 A kind of preparation method of Pranlukast
CN109824537A (en) * 2019-04-03 2019-05-31 重庆医药高等专科学校 A kind of preparation method of N-(3-acetyl-2-hydroxyphenyl) acetamide
CN110423204A (en) * 2019-08-09 2019-11-08 昆山力田医化科技有限公司 A kind of preparation method of Pranlukast intermediate
CN110423206A (en) * 2019-07-17 2019-11-08 天津大学 The method of cyclohexanone oxime, cyclohexanone and toluene is separated from Ammoximation reaction product
CN110938052A (en) * 2018-09-21 2020-03-31 重庆圣华曦药业股份有限公司 Industrial preparation method of intermediate of pranlukast as anti-asthma drug
CN111960957A (en) * 2020-09-09 2020-11-20 太仓康源化建医药有限公司 Preparation method of pranlukast intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395144A (en) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd Production of aminophenol derivative
JPH05279305A (en) * 1992-04-02 1993-10-26 Ono Pharmaceut Co Ltd Production of 3'-amino-2'-hydroxyacetophenone
CN101450943A (en) * 2008-11-10 2009-06-10 河北科技大学 Method for synthesizing drug pranlukast from tetrahydrofuran path

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395144A (en) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd Production of aminophenol derivative
JPH05279305A (en) * 1992-04-02 1993-10-26 Ono Pharmaceut Co Ltd Production of 3'-amino-2'-hydroxyacetophenone
CN101450943A (en) * 2008-11-10 2009-06-10 河北科技大学 Method for synthesizing drug pranlukast from tetrahydrofuran path

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
YUE ZHANG，等: "Synthesis of pranlukast", 《BIOTECHNOLOGY: AN INDIAN JOURNAL》 *
于欣红，等: "2-羟基-3-氨基苯乙酮盐酸盐的合成", 《化学世界》 *
李敬芬: "《药物合成反应》", 31 August 2010, 浙江大学出版社 *
田改仓，等: "《氮肥工业文集》", 31 July 1994, 华东理工大学出版社 *
顾翼东: "《化学词典》", 30 September 1989, 上海辞书出版社 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106995366A (en) * 2017-06-07 2017-08-01 上海微巨实业有限公司 A kind of novel preparation method of the hydroxy acetophenone of 3 amino 2
CN107098822A (en) * 2017-06-07 2017-08-29 上海微巨实业有限公司 A kind of preparation method for preparing the hydroxy acetophenone of 3 amino of Pranlukast key intermediate 2
CN107098822B (en) * 2017-06-07 2021-05-28 上海微巨实业有限公司 Preparation method for pranlukast key intermediate 3-amino-2-hydroxyacetophenone
CN108947984A (en) * 2018-09-17 2018-12-07 烟台万润药业有限公司 A kind of preparation method of Pranlukast
CN110938052A (en) * 2018-09-21 2020-03-31 重庆圣华曦药业股份有限公司 Industrial preparation method of intermediate of pranlukast as anti-asthma drug
CN109824537A (en) * 2019-04-03 2019-05-31 重庆医药高等专科学校 A kind of preparation method of N-(3-acetyl-2-hydroxyphenyl) acetamide
CN109824537B (en) * 2019-04-03 2021-12-28 重庆医药高等专科学校 Preparation method of N- (3-acetyl-2-hydroxyphenyl) acetamide
CN110423206A (en) * 2019-07-17 2019-11-08 天津大学 The method of cyclohexanone oxime, cyclohexanone and toluene is separated from Ammoximation reaction product
CN110423206B (en) * 2019-07-17 2022-07-08 天津大学 Method for separating cyclohexanone oxime, cyclohexanone and toluene from ammoximation reaction product
CN110423204A (en) * 2019-08-09 2019-11-08 昆山力田医化科技有限公司 A kind of preparation method of Pranlukast intermediate
CN111960957A (en) * 2020-09-09 2020-11-20 太仓康源化建医药有限公司 Preparation method of pranlukast intermediate

Similar Documents

Publication Publication Date Title
CN106588897A (en) New preparation method of Pranlukast
CN111423452B (en) Intermediates of Relugoli and their preparation methods and applications
CN110950765A (en) A kind of preparation method of terbutaline sulfate
CN109988077A (en) A kind of synthetic method and intermediate of A Palu amine
CN111606849B (en) A kind of synthetic method of 2-(2-aminophenyl) quinoline compounds
CN101863954B (en) Preparation method of N-tert-butyl-4-aza-5 alpha-androstane-3-ketone-17 beta-formamide
CN102898328B (en) Synthesis method of diethyl azodicarboxylate and intermediate of diethyl azodicarboxylate
CN103539728A (en) Synthesis method of lansoprazole drug intermediate chloromethyl pyridine derivative
US12258318B2 (en) Synthesis method for 1-methyl-1H-indazole-6-carboxylic acid
CN105294415A (en) Preparation method of 3-halogenated fluorenone compound
CN104774183B (en) A kind of auspicious relax of formoxyl cuts down the preparation method of spit of fland calcium intermediate
CN104672180B (en) Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate
CN109879805B (en) Preparation method of apatinib
CN110003101B (en) Apatinib intermediate and preparation method thereof
CN115073299B (en) Method for preparing 2-fluoro-3-trifluoromethyl aniline
CN114560862A (en) Synthesis method of pyrrolo [1,2-A ] quinoxaline-4 (5H) -ketone and derivative thereof
CN110128413B (en) 5-acetyl-4- (N-substituted carbazolyl) -6-methyl-3, 4-dihydropyrimidine-2-ketone and preparation method thereof
CN109232282B (en) Synthetic method of 2-aminobenzophenone compound
CN106831536A (en) A kind of preparation method of gliclazide green synthesis process
CN106831457A (en) A kind of new preparation process of the hydroxy acetophenone of 3 amino 2
CN106565625A (en) Preparation method for intermediates of new medicine Lusutrombopag resisting to thrombopenia
CN102000605A (en) Catalytic initiator Cu2(L)Cl2 of monovalent copper and its preparation method, preparation method of nitrogen heterocyclic aromatization product
CN103709089B (en) One prepares the method for 3-(4 '-chlorobutyl)-5-cyanoindole
CN102267980B (en) Method for preparing 2,6-bis(2-benzimidazolyl)pyridine
CN117024342B (en) A method for synthesizing phenanthridine OLED material

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170426

RJ01 Rejection of invention patent application after publication